Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11504363 Method of treating cancer and bone cancer pain

Patent 11504363 was granted and assigned to Exelixis on November, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Exelixis
Exelixis
0
Date Filed
February 11, 2020
0
Date of Patent
November 22, 2022
0
Patent Applicant
Exelixis
Exelixis
0
Patent Application Number
16787212
0
Patent Citations
‌
US Patent 11123338 C-met modulator pharmaceutical compositions
‌
US Patent 10034873 C-met modulator pharmaceutical compositions
0
‌
US Patent 10039757 C-Met modulator pharmaceutical compositions
0
‌
US Patent 10166225 Method for treating osteoporosis
0
‌
US Patent 11098015 Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
0
‌
US Patent 11141413 Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate
0
Patent Inventor Names
Gisela Schwab
0
Dana T. Aftab
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11504363
0
Patent Primary Examiner
‌
James D. Anderson
0
CPC Code
‌
A61P 35/04
0
‌
A61P 19/00
0
‌
A61K 31/536
0
‌
C07D 215/233
0
‌
A61K 31/47
0
‌
A61P 35/00
0

Find more entities like US Patent 11504363 Method of treating cancer and bone cancer pain

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo